Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026023
Filing Date
2021-05-10
Accepted
2021-05-10 16:01:01
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20210331.htm 10-Q 2412279
2 EX-10.1 idya-ex101_489.htm EX-10.1 60836
3 EX-31.1 idya-ex311_6.htm EX-31.1 18308
4 EX-31.2 idya-ex312_7.htm EX-31.2 18365
5 EX-32.1 idya-ex321_8.htm EX-32.1 12421
  Complete submission text file 0001564590-21-026023.txt   6971970

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idya-20210331.xml EX-101.INS 1224797
7 XBRL TAXONOMY EXTENSION SCHEMA idya-20210331.xsd EX-101.SCH 50517
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20210331_cal.xml EX-101.CAL 41352
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20210331_def.xml EX-101.DEF 177267
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20210331_lab.xml EX-101.LAB 408559
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20210331_pre.xml EX-101.PRE 315989
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 21906950
SIC: 2834 Pharmaceutical Preparations